一种新兴的自身免疫性神经炎症性疾病:髓寡基细胞糖蛋白抗体疾病抗体
Satbir Kaur Malik1, Atharvan Sharma Mangalapalli, Hemanjali Avuthu
1Department of Internal Medicine, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India.
Annals of African medicine
|September 15, 2025
概括
髓寡干细胞糖蛋白抗体疾病 (MOGAD) 是一种独特的自身免疫性疾病. 早期诊断和甲基前列尼索隆治疗导致MOGAD患者完全康复,显示出比其他脱髓化疾病更好的预后.
科学领域:
- 神经免疫学 神经免疫学
- 脱线性疾病 脱线性疾病
- 自身免疫性疾病 自身免疫性疾病
背景情况:
- 髓寡腺细胞糖蛋白抗体疾病 (MOGAD) 是一种自身免疫性神经炎症性脱髓化疾病.
- 现在,MOGAD被认为与多发性硬化症和AQP4-IgG+ NMOSD不同.
- 它涉及的抗体向MOG蛋白在髓和寡细胞上.
研究的目的:
- 报告一个40岁女性的MOGAD病例.
- 要突出临床表现,诊断发现和治疗反应.
- 为了强调MOGAD的独特特征和有利的预后.
主要方法:
- 临床表现:发烧,视力受损,心动不良,尿液保留.
- 诊断测试:脑脊液分析 (淋巴细胞多细胞症),阳性血清抗转基因抗体 (1:100).
- 磁共振成像 (MRI):大脑,大脑干,周周结膜白质和中枢的病变.
主要成果:
- 患者接受了脉冲甲基普雷迪尼索隆,随后是口服普雷迪尼索隆.
- 一年后完全康复,没有残留疾病.
- 重复的MOG抗体是负的;MRI显示了完整的病变分离.
结论:
- 莫加德具有独特的表现,对疾病修饰疗法反应良好.
- 与其他脱髓化疾病相比,MOGAD的预后更好,患病率更低.
- 高临床和放射学怀疑对于早期诊断和管理至关重要,以避免误诊.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
01:15Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K